These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16013954

  • 1. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
    Polanczyk G, Zeni C, Genro JP, Roman T, Hutz MH, Rohde LA.
    Pharmacogenomics; 2005 Apr; 6(3):225-34. PubMed ID: 16013954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T, Rohde LA, Hutz MH.
    Am J Pharmacogenomics; 2004 Apr; 4(2):83-92. PubMed ID: 15059031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH.
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C, Faraone SV, Scassellati C.
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM.
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.
    Rohde LA, Roman T, Szobot C, Cunha RD, Hutz MH, Biederman J.
    Synapse; 2003 May; 48(2):87-9. PubMed ID: 12619042
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J, Romanos M, Ettinger U.
    Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar 05; 147B(2):201-8. PubMed ID: 17955457
    [Abstract] [Full Text] [Related]

  • 20. Pharmacogenetic approach for a better drug treatment in children.
    Polanczyk G, Bigarella MP, Hutz MH, Rohde LA.
    Curr Pharm Des; 2010 Mar 05; 16(22):2462-73. PubMed ID: 20513229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.